Premium
Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial
Author(s) -
Galadanci Najibah A.,
Abdullahi Shehu U.,
Ali Abubakar Shehi,
Wudil Jibir Binta,
Aminu Hauwa,
Tijjani Aliyu,
Abba Muhammad S.,
Tabari Musa A.,
Galadanci Aisha,
Borodo Awwal Musa,
Belonwu Raymond,
Salihu Auwal S.,
Rodeghier Mark,
Ghafuri Djamila L.,
Covert C Greene Brittany V.,
Neville Kathleen,
Kassim Adetola A.,
Kirkham Fenella J.,
Jordan Lori C.,
Aliyu Muktar H.,
DeBaun Michael R.
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25900
Subject(s) - medicine , stroke (engine) , sickle cell anemia , transfusion therapy , pediatrics , adverse effect , transcranial doppler , anemia , blood transfusion , disease , mechanical engineering , engineering